Cowen Upgrades Emerson (EMR) to Outperform

August 5, 2020 5:33 AM EDT
Get Alerts EMR Hot Sheet
Price: $98.12 +0.70%

Rating Summary:
    15 Buy, 18 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 12 | New: 23
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Cowen analyst Gautam Khanna upgraded Emerson (NYSE: EMR) from Market Perform to Outperform with a price target of $70.00 (from $63.00).

The analyst comments "EMR has many investment merits: "knowable" demand headwinds, a well-defined restructuring (R/S) plan under proactive management, and a high dividend buttressed by strong liquidity. Over the next year, comps will be easy, and CEO Dave Farr will transition out, likely to a successor who will become obvious via performance through this downturn. We expect the stock to grind up to our $70 PT."

For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.

Shares of Emerson closed at $61.11 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Hot Comments, Hot Upgrades, Upgrades

Related Entities

Cowen & Co